J.E.B. Bolen
Known title: EVP OPERATIONSCIK: 0002041211
Associated companies
Transaction History
| EQT | ▼ Sell | Tax Withholding | 3,904 | $203K | 7/27/2026 | View on chart |
| EQT | ▼ Sell | Open Market | 7,634 | $491K | 3/12/2026 | View on chart |
| EQT | ▲ Buy | Grant | 8,630 | $0 | 3/9/2026 | View on chart |
| EQT | ▼ Sell | Tax Withholding | 3,754 | $234K | 3/9/2026 | View on chart |
| EQT | ▼ Sell | Tax Withholding | 931 | $54K | 2/17/2026 | View on chart |
| EQT | ▼ Sell | Tax Withholding | 1,140 | $67K | 2/13/2026 | View on chart |
| EQT | ▼ Sell | Tax Withholding | 885 | $52K | 2/13/2026 | View on chart |
| EQT | ▲ Buy | Grant | 19,520 | $0 | 2/11/2026 | View on chart |
| EQT | ▼ Sell | Open Market | 1,422 | $75K | 10/28/2025 | View on chart |
| EQT | ▲ Buy | Grant | 26,620 | $0 | 7/25/2025 | View on chart |
| EQT | ▲ Buy | Grant | 11,779 | $0 | 3/4/2025 | View on chart |
| EQT | ▼ Sell | Tax Withholding | 4,219 | $211K | 3/4/2025 | View on chart |
| EQT | ▼ Sell | Tax Withholding | 632 | $34K | 2/18/2025 | View on chart |
| EQT | ▼ Sell | Tax Withholding | 699 | $37K | 2/13/2025 | View on chart |
| EQT | ▲ Buy | Grant | 6,320 | $0 | 2/13/2025 | View on chart |
| EQT | ▼ Sell | Tax Withholding | 925 | $48K | 2/4/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
EQT Raises Dividend, Analysts Adjust Targets
EQT increased its quarterly cash dividend to $0.17 per share, up 3% from the previous level. The company reported a $100 million gain on derivatives for the quarter ending September 30, 2026, with $70 million in net cash settlements. Several analysts have revised their price targets downward, with UBS setting $76, Scotiabank $54, and Mizuho $68. These moves reflect a focus on shareholder returns amid changing market conditions.
EQT Raises Dividend, Analysts Adjust Targets. EQT increased its quarterly cash dividend to $0.17 per share, up 3% from the previous level. The company reported a $100 million gain on derivatives for the quarter ending September 30, 2026, with $70 million in net cash settlements. Several analysts have revised their price targets downward, with UBS setting $76, Scotiabank $54, and Mizuho $68. These moves reflect a focus on shareholder returns amid changing market conditions.